All tumor biomarkers, including CEA, CA19-9, CA15-3, CA125, CA72-4, CYFRA21-1 and NSE, showed no clear difference among the PR, SD and PD subgroups; Table II. This evidence concerns the gene CEACAM5 and neoplasm.